Cogent Biosciences, Inc. announced the appointment of Rachael Easton, MD, Ph.D., Vice President, Head of Clinical Development. Prior to joining Cogent, Dr. Easton was Group Senior Medical Director, Oncology Clinical Development at GSK?. Prior to GSK, she held clinical development roles of increasing responsibility at Immunocore and Sanofi.

Before transitioning into the biotechnology industry, Dr. Easton was an instructor at the University of Pennsylvania School of Medicine where she conducted research in growth and metabolism and provided outpatient care for patients with endocrine disorders. She earned her MD and Ph.D. in Molecular and Cellular Biology from Washington University School of Medicine, and her B.S. in Chemistry from Washington and Lee University.